Robert D Inman, BA, MD

Ankylosing Spondylitis is an autoimmune arthritis which is the most common form of inflammatory joint disease affecting the spine. The Spondylitis Program at Toronto Western Hospital plays a leading role in defining the genetic basis of this disease, developing new outcome measures and introducing innovative new biologic agents for the treatment of this disease.

Reactive Arthritis is a form of arthritis that is triggered by an infection. We are studying epidemic outbreaks across Canada to learn how genetic and environmental factors contribute to autoimmunity.

Immunology of Infection holds the promise of defining the genetic control of defence against bacterial infections. These translational studies incorporate clinical research, experimental models of arthritis and basic cellular and molecular immunology.

For a list of Dr. Inman's publications, please visit PubMed, Scopus or ORCID.

Co-Director, Schroeder Arthritis Institute
Deputy Physician in Chief Research, University Health Network
Director, Spondylitis Program, University Health Network
Professor, Department of Immunology, University of Toronto